The Incubator

Building the future with artificial intelligence, machine learning at Dakota State

Artificial intelligence isn’t just key to the future — it’s here now, and DSU is a leading center for studying it.

6 years ago

Pioneering COVID-19 treatment leads Sioux Falls biotech company to big opportunities for growth

“SAB is a very different company today than we were at the beginning of the year.” With unprecedented growth and a one-of-a-kind treatment for COVID-19, SAB Biotherapeutics is just getting started.

6 years ago

View this year’s TEDxSiouxFalls talks here

Sioux Falls speakers are now sharing their thought leadership with the world.

6 years ago

Sanford teams work across spectrum to find answers to COVID-19

Whether patients have mild COVID-19 symptoms or are seriously ill, there’s a team at Sanford Research working to address and combat every step of the novel coronavirus.

6 years ago

Innovation leader builds career while helping biotech startups achieve big milestones

She captured opportunities early in her career and now is helping scale up multiple biotech startups. Meet this rising industry leader.

6 years ago

Cancer test invention spurs business spinoff

She’s a scientist, a breast cancer survivor and now the inventor of a potentially game-changing test for cancer thanks to collaborations that show how far bioscience in Sioux Falls has come.

6 years ago

Bioscience leaders to share breakthroughs at upcoming South Dakota Biotech Summit

There has never been a better time to tap into what’s happening in South Dakota’s bioscience industry. And there has never been a more convenient way to do it.

6 years ago

Sanford first in the nation to dose patient with SAB’s COVID treatment

A first-of-its-kind approach to targeting COVID-19 has happened between two Sioux Falls-based organizations.

6 years ago

POET, Farmers Business Network partner on new network

Sioux Falls-based POET and Farmers Business Network, which has a large office in the city, are working together on a new network.

6 years ago

Avera chosen as site for experimental COVID-19 antibody trials

Avera Health will be part of three phase two and three clinical trials evaluating whether a combination of two lab-made antibodies can not only treat, but also prevent SARS-CoV-2, the virus that causes COVID-19.

6 years ago

News Tip

Have a business news item to share with us?

Scroll to top